Filed: 11/14/2025ACC: 0001750183-25-000016
📋 What this filing means
ANTARA CAPITAL LP filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $490.2K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$490.2K
Total AUM (reported)
673.79K
Total Shares
Allocation by class
CL A ORD SHS$442.2K90.2%
COM$41.8K8.5%
*W EXP 02/14/203$6.2K1.3%
Portfolio Concentration
Top 3$490.2K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 673.79K
Sole
Full voting authority
673.79K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
CURRENC GROUP INC
SOLEShares263.20K
TypeSH
Market value$442.2K
90.21%
Sole
263.20K
Shared
0.00
None
0.00
ASPIRE BIOPHARMA HLDGS INC
SOLEShares202.90K
TypeSH
Market value$41.8K
8.53%
Sole
202.90K
Shared
0.00
None
0.00
ASPIRE BIOPHARMA HLDGS INC
SOLEShares207.69K
TypeSH
Market value$6.2K
1.27%
Sole
207.69K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CURRENC GROUP INCSOLE | CL A ORD SHS | 263.20K | SH | $442.2K 90.21% | 263.20K | 0.00 | 0.00 |
ASPIRE BIOPHARMA HLDGS INCSOLE | COM | 202.90K | SH | $41.8K 8.53% | 202.90K | 0.00 | 0.00 |
ASPIRE BIOPHARMA HLDGS INCSOLE | *W EXP 02/14/203 | 207.69K | SH | $6.2K 1.27% | 207.69K | 0.00 | 0.00 |